Systemic Light Chain Amyloidosis.
作者信息
Marvisi Maurizio, Ramponi Sara
机构信息
Istituto Figlie di San Camillo, Cremona, Italy
出版信息
N Engl J Med. 2024 Sep 26;391(12):1164-1165. doi: 10.1056/NEJMc2409196.
PMID:39321375
Abstract
摘要
相似文献
1
Systemic Light Chain Amyloidosis.
N Engl J Med. 2024 Sep 26;391(12):1164-1165. doi: 10.1056/NEJMc2409196.
2
Systemic Light Chain Amyloidosis.
N Engl J Med. 2024 Sep 26;391(12):1165. doi: 10.1056/NEJMc2409196.
3
A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis.
Blood Cancer J. 2019 Feb 4;9(2):16. doi: 10.1038/s41408-019-0180-1.
4
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response.
Amyloid. 2017 Mar;24(sup1):54-55. doi: 10.1080/13506129.2017.1289916.
5
Systemic Light Chain Amyloidosis. Reply.
N Engl J Med. 2024 Sep 26;391(12):1165-1166. doi: 10.1056/NEJMc2409196.
6
Involved free light chains <10 mg/L with treatment predict better outcomes in systemic light-chain amyloidosis.
Am J Hematol. 2021 Jan;96(1):E20-E23. doi: 10.1002/ajh.26025. Epub 2020 Nov 5.
7
Diagnostic accuracy of new indirect ELISAs for free light-chain quantification in fat tissue of patients with AL amyloidosis.
Amyloid. 2017 Mar;24(sup1):46-47. doi: 10.1080/13506129.2017.1284058.
8
Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio.
Leukemia. 2019 Feb;33(2):527-531. doi: 10.1038/s41375-018-0258-y. Epub 2018 Sep 26.
9
A Case of Immunoglobulin Light Chain Hepatic Amyloidosis with Abdominal Hematoma.
Dig Dis Sci. 2024 Jul;69(7):2267-2269. doi: 10.1007/s10620-024-08342-8. Epub 2024 Mar 30.
10
AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
BMC Nephrol. 2018 Nov 22;19(1):337. doi: 10.1186/s12882-018-1050-y.
Zotero 插件